Therapeutic Potential of Phosphoinositide 3-Kinase &dgr;-Selective Small Molecule Inhibitors

By  

Current Enzyme Inhibition, Vol. 2, Iss. 2, 2006-05 ,pp. : 147-161

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia

By López Abraham   Mendieta Laura   Prades Roger   Royo Soledad   Tarragó Teresa   Giralt Ernest  

Future Medicinal Chemistry, Vol. 5, Iss. 13, 2013-09 ,pp. : 1509-1523

Future Science

Access to resources Recommend Favorite

Interplay Between the p53 Tumor Suppressor Protein Family and Cdk5: Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases Using Selective Cdk Inhibitors

By  

Molecular Neurobiology, Vol. 34, Iss. 1-2, 2006-08 ,pp. : 27-50

Humana Press, Inc

Access to resources Recommend Favorite

Interplay between the p53 tumor suppressor protein family and Cdk5: Novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors

By Schmid Gerald   Strosznajder Joanna   Węsierska-Gdek Józefa  

Molecular Neurobiology, Vol. 34, Iss. 1, 2006-08 ,pp. : 27-49

Humana Press, Inc

Access to resources Recommend Favorite

Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors

By Bonneau Adeline  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 2, 2013-04 ,pp. : 397-401

Informa Healthcare

Access to resources Recommend Favorite